Which breathing aid works best after surgery? new trial aims to find out
NCT ID NCT06988111
First seen Jun 25, 2026 · Last updated Jun 25, 2026
Summary
This study compares two noninvasive breathing devices—BIPAP and a high-velocity nasal cannula—to see which helps patients recover faster from respiratory failure after major surgery. About 180 adults who develop breathing problems within 48 hours after surgery will be randomly assigned to one of the two devices. The main goal is to see how many days it takes for each patient to no longer need breathing support.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY FAILURE WITHOUT HYPERCAPNIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Assuit Univeristy
RECRUITINGAsyut, Assuit, 71515, Egypt
Contact Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Breathing devices (BIPAP and Vapotherm)
What this could lead to
If successful, this could show which device helps patients recover faster and avoid invasive breathing tubes after surgery.
What could go wrong
This is a single-center trial with 180 participants, so results may not apply to all hospitals. The study is early and does not test a new drug or cure.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.